Table 3.
Distribution of HLA class II specificities in 33 AA patients and 112 controls, seen at the Dermatology Ambulatory of the Presidente Prudente Regional Hospital, São Paulo State, Brazil
| Allele Group | Patients n(f) | Controls n(f) | Alleles | Patients n(f) | Controls n(f) |
|---|---|---|---|---|---|
| DRB1 | DQA1 | ||||
| DRB1*01 | 06(9.1) | 20(8.9) | DQA1*01 | 31(46.9) | 34(50.0) |
| DRB1*03 | 06(9.1) | 22(9.8) | DQA1*02 | 02(3.0) | 06(8.8) |
| DRB1*04 | 08(12.1) | 25(11.2) | DQA1*03 | 09(13.6) | 06(8.8) |
| DRB1*07a | 02(3.0) | 22(9.8) | DQA1*04 | 03(4.5) | 03(4.4) |
| DRB1*08 | 04(6.1) | 14(6.2) | DQA1*05 | 21(31.8) | 19(27.9) |
| DRB1*09 | 01(1.5) | 03(1.3) | |||
| DRB1*10 | 01(1.5) | 06(2.7) | DQB1 | ||
| DRB1*11 | 13(19.7) | 35(15.6) | DQB1*02 | 08(12.1) | 15(22.1) |
| DRB1*12 | 01(1.5) | 05(2.2) | DQB1*03 | 25(37.9) | 16(23.5) |
| DRB1*13 | 12(18.2) | 25(11.2) | DQB1*04 | 02(3.0) | 03(4.4) |
| DRB1*14 | 01(1.5) | 12(5.4) | DQB1*05 | 14(21.2) | 20(29.4) |
| DRB1*15 | 06(9.1) | 26(11.6) | DQB1*06 | 17(25.8) | 14(20.6) |
| DRB1*16 | 05(7.6) | 09(4.0) |
n= number of specificities; (f)= frequency of specificities; OR= odds ratio CI= confidence of interval; Pc= P corrected;
a
HLA-DRB1*07: 3.0 vs 9.8; P=0.04; PC=0.52; OR= 0.29; 95%; CI= 0.07-1.25.